KNC Laboratories. 

¥1,248
3
-¥4-0.32% 06:30 Today

Statistics

Day High
1,250
Day Low
1,235
52W High
1,418
52W Low
1,060
Volume
2,300
Avg. Volume
3,965
Mkt Cap
9.71B
P/E Ratio
11.04
Dividend Yield
2.64%
Dividend
32.89

Upcoming

Dividends

2.64%Dividend Yield
Jun 26
¥17
Dec 25
¥16
Jun 25
¥17
Dec 24
¥16
Jun 24
¥15
10Y Growth
-52.79%
5Y Growth
5.71%
3Y Growth
5.63%
1Y Growth
N/A

Earnings

6NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.5
27.38
56.25
85.12
Expected EPS
N/A
Actual EPS
N/A

Financials

9.01%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
8.18BRevenue
737.33MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6568.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. competes in the pharmaceutical sector, developing products that can overlap with KNC Laboratories' healthcare offerings.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. operates in the same industry, focusing on pharmaceuticals and chemicals, directly competing with KNC's product lines.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. is a major player in the pharmaceutical industry in Japan, offering similar products and competing in the same markets as KNC Laboratories.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, a field relevant to KNC Laboratories' interests in medical and health-related products.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. is involved in the development of pharmaceutical solutions and life sciences, areas where KNC Laboratories also operates.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited focuses on pharmaceuticals, including research and development in medicine, competing with KNC Laboratories in healthcare solutions.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse range of pharmaceutical products, directly competing with KNC Laboratories in multiple healthcare segments.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on pharmaceuticals and biotechnologies, directly competing with KNC Laboratories in the development of medical treatments and solutions.
Nano
4571.TSE
Mkt Cap14.49B
Nippon Shinyaku Co., Ltd. competes in the pharmaceutical industry, offering products that can directly compete with KNC Laboratories' offerings.
Fujifilm
4901.TSE
Mkt Cap2.83T
Fujifilm Holdings Corporation, though primarily known for imaging, also has significant healthcare divisions that compete with KNC Laboratories in medical products and innovations.

About

KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. Its operations are carried out through the following business divisions: Functional Materials Business, Pharmaceutical Business, and Bio Business. The Functional Materials Business division provides display materials, chemicals for semiconductor manufacturing, carbon nanotube dispersions, etc. The Pharmaceutical Business division provides compounds for pharmaceutical research and development. The Bio Business Division provides auxiliary agents for antibody drug manufacturing. The company was founded on January 22, 1985 and is headquartered in Kobe, Japan.
Show more...
CEO
Takuya Maoka
Employees
340
Country
Japan
ISIN
JP3290400005
WKN
000A2JK64

Listings

0 Comments

Share your thoughts

FAQ

What is KNC Laboratories. stock price today?
The current price of 6568.TSE is ¥1,248 JPY — it has decreased by -0.32% in the past 24 hours. Watch KNC Laboratories. stock price performance more closely on the chart.
What is KNC Laboratories. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange KNC Laboratories. stocks are traded under the ticker 6568.TSE.
Is KNC Laboratories. stock price growing?
6568.TSE stock has fallen by -0.08% compared to the previous week, the month change is a -1.19% fall, over the last year KNC Laboratories. has showed a +10.34% increase.
What is KNC Laboratories. market cap?
Today KNC Laboratories. has the market capitalization of 9.71B
When is the next KNC Laboratories. earnings date?
KNC Laboratories. is going to release the next earnings report on November 06, 2026.
What were KNC Laboratories. earnings last quarter?
6568.TSE earnings for the last quarter are 5.14 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is KNC Laboratories. revenue for the last year?
KNC Laboratories. revenue for the last year amounts to 8.18B JPY.
What is KNC Laboratories. net income for the last year?
6568.TSE net income for the last year is 737.33M JPY.
Does KNC Laboratories. pay dividends?
Yes, 6568.TSE dividends are paid semi-annual. The last dividend per share was 17 JPY. As of today, Dividend Yield (FWD)% is 2.64%.
How many employees does KNC Laboratories. have?
As of September 11, 2026, the company has 340 employees.
In which sector is KNC Laboratories. located?
KNC Laboratories. operates in the Materials sector.
When did KNC Laboratories. complete a stock split?
KNC Laboratories. has not had any recent stock splits.
Where is KNC Laboratories. headquartered?
KNC Laboratories. is headquartered in Kobe, Japan.